US20120215249A1 - Compressive Device for Percutaneous Treatment of Obesity - Google Patents
Compressive Device for Percutaneous Treatment of Obesity Download PDFInfo
- Publication number
- US20120215249A1 US20120215249A1 US13/458,759 US201213458759A US2012215249A1 US 20120215249 A1 US20120215249 A1 US 20120215249A1 US 201213458759 A US201213458759 A US 201213458759A US 2012215249 A1 US2012215249 A1 US 2012215249A1
- Authority
- US
- United States
- Prior art keywords
- stomach
- connector
- anchor
- balloon
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
- A61F5/0033—Implantable devices or invasive measures inflatable with more than one chamber
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0073—Implantable devices or invasive measures in the abdominal cavity, e.g. not attached to the stomach
Definitions
- This invention pertains to multiple expandable devices that can be implanted to treat obesity in mammals by reducing the volume of the stomach.
- Obesity is a complex, medical disease affecting more than 30% of the population in the United States.
- Obesity affects an individual's personal quality of life and contributes significantly to morbidity and mortality.
- Obese patients i.e. individuals having a body mass index (“BMI”) greater than 30, often have a high risk of associated health problems (e.g., diabetes, hypertension, and respiratory insufficiency), including early death.
- BMI body mass index
- associated health problems e.g., diabetes, hypertension, and respiratory insufficiency
- In the United States approximately 280,000 deaths annually are attributed to obesity and obesity-related diseases.
- studies have shown that conservative treatment with diet and exercise may be ineffective for reducing excess body weight.
- specific diets, medications, behavioral modifications, and exercise programs have over a 95% failure rate in morbidly obese individuals.
- “Bariatric surgery” is the field of surgery that treats people who are so overweight that they are suffering health consequences due to the excess weight. The surgery usually involves operations on the stomach to restrict one's ability to eat, or on the small intestine to restrict the absorption of ingested food. See M. Deitel, “Overview of Obesity Surgery,” World J. Surg ., vol. 22, pp. 913-918 (1998).
- a successful bariatric surgery results in a maintained weight loss of greater than 50% of excess body weight and in an increase in patient wellness.
- An important factor for success is a long-term relationship between the patient and a medical team, which includes the doctor performing the procedure, a dietitian, a psychologist, and a physical therapist. While current bariatric surgery may assist patients in reducing food intake, it may also increase medical risks due to complications inherently associated with surgery, including complications of anesthesia, surgical procedure, wound infections, dehiscence, stomal stenosis, marginal ulcers, thrombophlebitis, and pulmonary problems.
- Biliopancreatic diversion surgery is a reduction of the stomach volume and a diversion of food from the stomach to the final segment of the small intestine, bypassing the beginning and middle portions of the small intestine to limit the amount of nutrients and calories absorbed by the body. This procedure removes about one half of the stomach, and then connects the stomach to the last 250 cm of the small intestine. Disadvantages of this surgery include patients suffering from protein malnutrition, anemia, gastric retention, diarrhea, abdominal bloating, and intestinal obstruction. See P. Marceau, et al., “Malabsorptive Obesity Surgery,” Surg. Clinics of North America , vol. 81(5), pp. 1113-28 (2001).
- gastric bypass Another bariatric surgery, “gastric bypass,” is a bypass connecting the lower compartment of the stomach to the initial portion of the small intestine. This procedure limits the amount of food that can be ingested at one sitting and reduces absorption of food across the small intestine. In addition to surgical complications, patients may also suffer from acute gastric dilation, anastomotic leak, anemia, and dumping syndrome. See R. E. Brolin, “Gastric Bypass,” Surg. Clinics of North America , vol. 81(5), pp. 1077-1096 (2001).
- a third bariatric surgical procedure is “gastric banding,” which constricts the stomach to form an hourglass shape. This procedure restricts the amount of food that passes from one section to the next, which induces a feeling of satiety.
- a band is placed around the stomach near the junction of the stomach and esophagus. The small upper stomach pouch is filled quickly, and slowly empties through the narrow outlet to produce a feeling of satiety.
- patients undergoing this procedure may also suffer from esophageal injury, splenic injury, band slippage, staple line disruption, reservoir deflation/leak, and persistent vomiting. See E. J. DeMaria, “Laparoscopic Adjustable Silicone Gastric Banding,” Surg. Clinics of North America ,” vol. 81(5), pp. 1129-44 (2001).
- a fourth bariatric surgical procedure is “vertical-banded gastroplasty,” which restricts the volume of the stomach by using staples.
- staples are placed in the upper stomach region to create a small pouch with a narrow outlet to the remaining portion of the stomach.
- a lap-band is placed around the narrow outlet to provide support and inhibit stretching of the stomach.
- patients undergoing this procedure may suffer from vomiting, ulcers, band erosion, and leaks. See C. Doherty, “Vertical Banded Gastroplasty,” Surg. Clinics of North America , vol. 81(5), pp. 1097-1112 (2001).
- U.S. Pat. No. 6,102,922 describes a device and surgical method for reducing the food intake of a patient by forming a restriction in the stomach using a band.
- the band is looped around the esophagus and a portion of the stomach is pulled up through the band loop. This forms a small stomach pouch and a narrow outlet to the remaining portion of the stomach. This allows for a quick filling of the small stomach pouch, and a slow emptying of the stomach through the narrow outlet to produce a feeling of satiety.
- U.S. Pat. No. 6,475,136 describes a device for treating heartburn and reflux disease by restricting the amount of food flowing into a stomach or an esophagus, comprising a restriction device (a sphincter or a cuff) that can be adjusted.
- the restriction device performs like an artificial sphincter that opens and closes the food passageway in the stomach.
- the restriction device comprises an adjustable cuff, a clamp, or a roller to bend or rotate the esophagus or stomach to close or almost close the junction between the stomach and esophagus.
- U.S. Pat. No. 4,246,893 describes a device and method for treating obesity by compressing the stomach and reducing its capacity using a single adjustable distensible device (e.g., a balloon) whose volume can be adjusted from an external port.
- a single adjustable distensible device e.g., a balloon
- U.S. Pat. No. 5,993,473 and WO 99/25418 describe a device and surgical method for treating obesity by decreasing the volume of the stomach by using a single expandable device placed inside the stomach cavity.
- U.S. Pat. No. 4,694,827 describes a device and method for controlling obesity by deterring ingestion of food using a single balloon that is placed inside the stomach.
- U.S. Publication No. 2002/0188354 describes a device for treating obesity by inserting an hourglass-shaped device into the junction between the stomach and the small bowel, which delays gastric emptying of food.
- U.S. Pat. No. 6,511,490 describes a device for the treatment of morbid obesity by restricting food passage in the stomach by placing an inflatable band around the stomach to create a pouch with a small opening adjacent to the esophagus. The inflatable band is secured and then inflated until the appropriate sized opening is achieved.
- the device reduces the gastric volume of the stomach and induces early satiety.
- the “gastric reduction assembly” comprises at least two or more expandable devices (e.g., balloons), each able to be independently inflated and adjusted from an external port.
- Each expandable device can be filled with a fluid (e.g., CO2, isotonic dextrose solution, isotonic saline solution, etc.) using a filling tube (e.g., a catheter), which can be easily accessed externally.
- a fluid e.g., CO2, isotonic dextrose solution, isotonic saline solution, etc.
- the gastric reduction assembly is inserted percutaneously through the antero-lateral abdominal wall, and placed at a location exterior to the stomach body, avoiding an abdominal incision. Laparoscopic guidance, optionally, may be used to assist in placing the gastric reduction assembly near the stomach body. Once positioned near the stomach body, the gastric reduction assembly can be inflated to compress the volume of the stomach and effectively limit food intake.
- the gastric reduction assembly with multiple expandable devices, minimizes the potential for post-implantation movement.
- the expandable devices have a size and shape to complement each other, such that they form a barrier when inflated that minimizes post implantation movement.
- a subcutaneous anchor e.g., a balloon or ring placed within the fatty layer between the skin and the abdominal wall
- each expandable device may use an intragastric anchor (e.g., a collapsible fixation disc) to anchor the expandable device against the stomach body.
- an intragastric anchor e.g., a collapsible fixation disc
- FIG. 1 illustrates a perspective view of one embodiment of the gastric reduction assembly, implanted in the peritoneal cavity around the stomach.
- FIG. 2 illustrates a front view of one embodiment of the gastric reduction assembly which has three expandable devices: two spherical-shaped and one crescent-shaped.
- the invention provides a reliable, inexpensive method for treating obesity in mammals by reducing the volume of the stomach without abdominal surgery, thus reducing postoperative surgical complications.
- the gastric reduction assembly can provide either an intraperitoneal or an extraperitoneal method to compress the stomach. The placement depends on the surgeon's preference, and the physical condition and body habitus of the patient.
- expandable devices can be placed either at a pregastric location (i.e., either anterior or anterolateral to the stomach) or a retrogastric location (i.e., either posterior or posterolateral to the stomach), or both.
- the expandable devices can be placed in any of the anatomical compartments, spaces, or layers of the abdominal wall.
- Candidates for this minimally invasive procedure include patients with a BMI greater than 40, or patients with a BMI less than 40 and a debilitating disease related to the obesity such as diabetes, hypertension, and respiratory insufficiency.
- the basic design comprises a gastric reduction assembly having at least two or more expandable devices (e.g., balloons), each able to be adjusted and independently inflated.
- Each device can be inflated with a fluid (e.g., CO 2 , isotonic dextrose solution, isotonic saline solution, etc.) using a filling tube.
- the filling tube is accessed externally by way of an access device.
- a carrier e.g., a hypodermic syringe
- Fluid flows through the filling tube into each expandable device.
- fluid can be removed by reversing the process.
- the filling tubes may be locked together inside a single catheter or other large tubing such that only one tube crosses the abdominal wall to the access port.
- compression of the stomach is achieved using two or more spherical-shaped expandable devices to form a compressive barrier that reduces the volume of the stomach and minimizes post-implantation movement.
- at least one crescent-shaped expandable device may be used to support the spherical-shaped expandable devices.
- the shape of the barrier formed by the multiple expandable devices may be adjusted to complement that of surrounding tissues and organs of the patient by changing the volume of the devices.
- a subcutaneous anchor may be used to help anchor the expandable devices to the abdominal wall.
- the subcutaneous anchor is a balloon-like device adapted to circumscribe the filling tubes subcutaneously or below the abdominal wall, at the muscular layer level. The volume of the subcutaneous anchor is adjusted by adding fluid.
- a ring lock may be placed around each filling tube at the muscular layer.
- the expandable devices may be anchored to the stomach using an anchor e.g., a collapsible, fixation disc placed inside the stomach.
- One method of placement is to pass the intragastric anchor through a separate tube that crosses the expandable device and ends inside the stomach cavity. The tube can be accessed externally.
- the expandable devices can be implanted by passing through the skin and across the anterior abdominal wall via a larger tube to a predetermined implantation site.
- the expandable devices remain at the site, attached to filling tubes that can be accessed externally through a small single access port.
- the gastric reduction assembly has several advantages. First, the potential for incisional hernia and wound infections is substantially reduced, since no surgical incision of the abdominal wall is needed.
- the expandable devices are inserted through the skin and across the anterior abdominal wall via a small puncture.
- the access device for refilling or deflating the expandable devices is placed in the fatty layers of the abdomen, between the skin and the anterior abdominal muscles.
- Second, post-implantation movement is substantially reduced, almost eliminating a need to re-orient the expandable devices following implantation. Third, modifications (e.g., inflation, deflation, reorientation, or removal) may easily be done without surgery.
- FIG. 1 illustrates a perspective view of one embodiment of the gastric reduction assembly 2 , in accordance with the present invention.
- the device comprises an access device 6 , a subcutaneous anchor 8 , and at least two or more expandable devices 4 , each having an intragastric anchor 10 and a filling tube 12 .
- Multiple expandable devices 4 are sized and shaped to complement each other such that when inflated, they cluster to form a compressive barrier capable of reducing the stomach volume and minimizing post-implantation movement.
- fluid is injected into each filling tube 12 of each expandable device 4 via the access device 6 .
- gastric reduction assembly 2 comprises three spherical-shaped expandable devices 4 (e.g., balloons) placed at a pregastric location.
- gastric reduction assembly 2 may comprise another number of expandable devices 4 (e.g., two, four, five, six, etc.).
- at least one crescent-shaped expandable device 13 may be used, as shown in FIG. 2 . This enhances the compressive barrier by forming a carrier ridge to support spherical-shaped expandable devices 4 .
- Expandable devices 4 can be made of any durable, distensible biocompatible material, such as rubber, latex, or polyurethane elastomer.
- each filling tube 12 has an inlet at the access device 6 and an outlet to the interior of each expandable device 4 to allow for inflation with fluid.
- a single filling tube 12 that has an inlet and outlet (not shown) for each expandable device 4 may be used.
- Filling tubes 12 should be made of a durable, flexible, biocompatible material, such as TYGON® tubing, polyurethane, or other plastics.
- subcutaneous anchor 8 is a distensible balloon-like device that circumscribes filling tubes 12 within the fatty layer between the skin and abdominal wall or at a subperitoneal (i.e., below the abdominal wall) region to anchor the expandable devices 4 to the abdominal wall.
- the balloon-like device is inflated via its own filling tube 14 .
- subcutaneous anchor 8 can be a ring lock (not shown) that joins all filling tubes 12 . When the ring lock is placed around filling tubes 12 and advanced towards the abdominal wall, it forms an anchor against the muscular layer of the abdominal wall.
- Subcutaneous anchor 8 should be made of a durable, distensible biocompatible material, such as rubber, latex, or polyurethane elastomer.
- intragastric anchor 10 is a collapsible, fixation disc which can be inserted through the stomach wall via tube 12 with a second channel 16 that extends through each expandable device 4 .
- the disc once opened in the stomach, anchors expandable device 4 against the stomach.
- intragastric anchor 10 Once intragastric anchor 10 is positioned within the stomach and unfolds, an attached suture may be pulled to form a snug fit between the exterior surface of the stomach body and expandable devices 4 .
- the size and shape of intragastric anchor 10 is chosen to complement the inner surface of the stomach, and to provide a sufficient surface area (when unfolded) to prevent intragastric anchor 10 from dislodging from the stomach when tension is applied.
- Intragastric anchor 10 should be made of a biocompatible material capable of shape memory, e.g., nitinol coated with polytetrafluoroethylene.
- An access device 6 comprises ports (not shown) to filling tubes 12 .
- the size and shape of access device 6 is adapted to allow for a tight seal with filling tubes 12 and a fluid carrier (e.g., a hypodermic syringe).
- the number of ports is determined by the number of tubes ( 12 and 14 ) that need to be accessed from the outside.
- a preferred method of implanting the gastric reduction assembly is to go though the skin with a minimally invasive puncture.
- a nasogastric tube (Bard, Covington, Ga.) is inserted into the stomach.
- the stomach is then inflated to better visualize it under fluoroscopy so that the proper location for an access site through the skin can be determined.
- the access site should be below the rib cage, near the gastric chamber.
- a micropuncture needle e.g., 22 g; Cook, Inc., Bloomington, Ind.
- a microwire (e.g., 0.018 in; Cook, Inc., Bloomington, Ind.) is passed through the needle under fluoroscopic guidance and into the peritoneal cavity. Once the microwire reaches the peritoneal cavity, the micropuncture needle is removed over the wire.
- An access sheath e.g., 6 French introducer; Cook, Inc., Bloomington, Ind.
- a hollow tube that fits through the skin to form a temporary pathway to the peritoneal cavity, is then inserted over the microwire.
- the microwire is then removed, leaving the access sheath in place.
- a guidewire e.g., 0.035 in stiff regular or hydrophilic; Boston Scientific, Natick, Massachusetts.
- the opening in the abdominal wall is progressively dilated with dilators (Cook, Inc. Bloomington, Ind.) from 6-14 French.
- a larger access sheath e.g., 14 Fr peel-away sheath; Cook, Inc. Bloomington, Indiana
- Air is then evacuated from the stomach through the nasogastric tube to provide space for the gastric compression assembly 2 .
- Introducer tubes e.g., catheters
- expandable devices 4 e.g., balloons
- the expandable devices 4 are then partially inflated sequentially near the stomach using a syringe to introduce fluid (e.g., CO2, isotonic saline solution, or isotonic dextrose solution) to the expandable devices 4 through the filling tubes 12 .
- fluid e.g., CO2, isotonic saline solution, or isotonic dextrose solution
- a subcutaneous anchor 8 e.g., a balloon or ring lock
- Expandable devices 4 are then inflated to a volume sufficient to compress the stomach, and filling tubes 12 cut to an appropriate length.
- the inlets to filling tubes 12 are then attached to the ports of access device 6 , and access device 6 is placed within the fatty layer between the skin and abdominal wall. The skin is then closed with sutures.
- each expandable device 4 is individually introduced to a preselected stomach compression site near the stomach and then anchored to the stomach, as described below.
- filling tube 12 to each expandable device 4 has at least two channels.
- Filing tube 12 is positioned to pass through expandable device 4 and abut the side of expandable device 4 that is near the stomach.
- One channel of filling tube 12 has an opening that allows fluid to flow into expandable device 4 to inflate the device.
- the second channel of filling tube 12 passes intact through expandable device 4 to the wall near the stomach. This channel allows an intragastric anchor 10 to be placed inside the stomach to help anchor expandable device 4 as described below.
- a needle e.g., an 18-gauge needle; Cook, Inc.
- Bloomington, Ind. is passed through the access sheath to puncture the stomach wall.
- a contrast medium e.g. gastrograffin
- a suture 22 is attached to intragastric anchor 10 , and the collapsed anchor is advanced through the needle into the stomach in a collapsed form using a stiff guidewire (e.g., 0.035 cm guidewire; Boston Scientific Corp, Natick, Mass.).
- intragastric anchor 10 Upon exiting the needle outlet within the stomach, intragastric anchor 10 resumes its disc-shaped configuration.
- Intragastric anchor 10 can be covered with a biocompatible material (e.g., GORTEX®, DACRON®, polyethylene or silicone) to help seal the gastric puncture site.
- the 18-gauge needle is then removed, while the stiff guidewire and suture remain attached to the intragastric anchor 10 .
- suture 22 is attached to the guidewire to allow for withdrawal. This process is repeated for each of the remaining expandable devices 4 .
- the stiff guidewire is then passed through the second channel of filling tube 12 for each expandable device 4 .
- Expandable devices 4 are then positioned at preselected stomach compression sites as described above. After verifying the compressive effects of each expandable device 4 on the gastric volume of the stomach, the stiff guidewires are disconnected from sutures 22 and removed. Each suture 22 is then pulled back through the second channel of filling tube 12 to anchor the device to the stomach wall. The access sheath is then removed, and filling tubes 12 are cut to an appropriate length.
- each suture is pulled through the second channel and attached to access device 6 to anchor expandable devices 4 .
- Expandable devices 4 can then be inflated or deflated through access device 6 , as necessary.
- Access device 6 is then placed within the fatty layer between the skin and the abdominal wall, and the skin is closed with sutures.
- Clinical trials will initially involve testing two groups (a test and a control) of pigs weighing more than 50 kg.
- the gastric reduction assembly will be implanted into the test group.
- an upper gastrointestinal study (“UGI”) will be conducted with barium to check the gastric volume and passage of material through the stomach into the small intestine.
- the volume of the expandable devices will be adjusted in the test group based on the findings of the UGI.
- UGIs will be conducted at various intervals to check on the location and volume of the expandable devices.
- the two groups will be weighed weekly. After six months, the animals will be euthanized and the position of the gastric reduction assembly evaluated during necropsy. The data will be analyzed for differences in weight loss between the two groups.
Abstract
An apparatus and method for treating morbid obesity in mammals using a gastric reduction assembly that reduces the gastric volume of a stomach and induces early satiety. The gastric reduction assembly comprises at least two or more expandable devices, each able to be adjustably inflated with a fluid (e.g., a liquid or a gas) using a filling tube. In a preferred embodiment, the gastric reduction assembly is inserted through the abdominal wall and placed at a location exterior to the stomach body, avoiding an abdominal incision. Once positioned near the stomach body, the gastric reduction assembly allows for the external compression of the stomach body to limit food intake. The gastric reduction assembly also minimizes the potential for shifting of the expandable devices after insertion to the stomach body to revert to its pre-compressed state.
Description
- The benefit of the filing date of provisional application Ser. No. 60/494,698, filed 13 Aug. 2003 is claimed under 35 U.S.C. §119(e).
- This invention pertains to multiple expandable devices that can be implanted to treat obesity in mammals by reducing the volume of the stomach.
- Obesity is a complex, medical disease affecting more than 30% of the population in the United States. Obesity affects an individual's personal quality of life and contributes significantly to morbidity and mortality. Obese patients, i.e. individuals having a body mass index (“BMI”) greater than 30, often have a high risk of associated health problems (e.g., diabetes, hypertension, and respiratory insufficiency), including early death. In the United States, approximately 280,000 deaths annually are attributed to obesity and obesity-related diseases. In the case of morbid obesity, studies have shown that conservative treatment with diet and exercise may be ineffective for reducing excess body weight. In addition, specific diets, medications, behavioral modifications, and exercise programs have over a 95% failure rate in morbidly obese individuals. Consequently, surgery is often the most effective means of treatment. “Bariatric surgery” is the field of surgery that treats people who are so overweight that they are suffering health consequences due to the excess weight. The surgery usually involves operations on the stomach to restrict one's ability to eat, or on the small intestine to restrict the absorption of ingested food. See M. Deitel, “Overview of Obesity Surgery,” World J. Surg., vol. 22, pp. 913-918 (1998).
- A successful bariatric surgery results in a maintained weight loss of greater than 50% of excess body weight and in an increase in patient wellness. An important factor for success is a long-term relationship between the patient and a medical team, which includes the doctor performing the procedure, a dietitian, a psychologist, and a physical therapist. While current bariatric surgery may assist patients in reducing food intake, it may also increase medical risks due to complications inherently associated with surgery, including complications of anesthesia, surgical procedure, wound infections, dehiscence, stomal stenosis, marginal ulcers, thrombophlebitis, and pulmonary problems.
- There are several bariatric surgical procedures for treating morbid obesity. One procedure for treating morbid obesity is referred to as a “biliopancreatic diversion.” Biliopancreatic diversion surgery is a reduction of the stomach volume and a diversion of food from the stomach to the final segment of the small intestine, bypassing the beginning and middle portions of the small intestine to limit the amount of nutrients and calories absorbed by the body. This procedure removes about one half of the stomach, and then connects the stomach to the last 250 cm of the small intestine. Disadvantages of this surgery include patients suffering from protein malnutrition, anemia, gastric retention, diarrhea, abdominal bloating, and intestinal obstruction. See P. Marceau, et al., “Malabsorptive Obesity Surgery,” Surg. Clinics of North America, vol. 81(5), pp. 1113-28 (2001).
- Another bariatric surgery, “gastric bypass,” is a bypass connecting the lower compartment of the stomach to the initial portion of the small intestine. This procedure limits the amount of food that can be ingested at one sitting and reduces absorption of food across the small intestine. In addition to surgical complications, patients may also suffer from acute gastric dilation, anastomotic leak, anemia, and dumping syndrome. See R. E. Brolin, “Gastric Bypass,” Surg. Clinics of North America, vol. 81(5), pp. 1077-1096 (2001).
- A third bariatric surgical procedure is “gastric banding,” which constricts the stomach to form an hourglass shape. This procedure restricts the amount of food that passes from one section to the next, which induces a feeling of satiety. A band is placed around the stomach near the junction of the stomach and esophagus. The small upper stomach pouch is filled quickly, and slowly empties through the narrow outlet to produce a feeling of satiety. In addition to surgical complications, patients undergoing this procedure may also suffer from esophageal injury, splenic injury, band slippage, staple line disruption, reservoir deflation/leak, and persistent vomiting. See E. J. DeMaria, “Laparoscopic Adjustable Silicone Gastric Banding,” Surg. Clinics of North America,” vol. 81(5), pp. 1129-44 (2001).
- A fourth bariatric surgical procedure is “vertical-banded gastroplasty,” which restricts the volume of the stomach by using staples. In this procedure, staples are placed in the upper stomach region to create a small pouch with a narrow outlet to the remaining portion of the stomach. A lap-band is placed around the narrow outlet to provide support and inhibit stretching of the stomach. In addition to surgical complications, patients undergoing this procedure may suffer from vomiting, ulcers, band erosion, and leaks. See C. Doherty, “Vertical Banded Gastroplasty,” Surg. Clinics of North America, vol. 81(5), pp. 1097-1112 (2001).
- U.S. Pat. No. 6,102,922 describes a device and surgical method for reducing the food intake of a patient by forming a restriction in the stomach using a band. In one embodiment, the band is looped around the esophagus and a portion of the stomach is pulled up through the band loop. This forms a small stomach pouch and a narrow outlet to the remaining portion of the stomach. This allows for a quick filling of the small stomach pouch, and a slow emptying of the stomach through the narrow outlet to produce a feeling of satiety.
- U.S. Pat. No. 6,475,136 describes a device for treating heartburn and reflux disease by restricting the amount of food flowing into a stomach or an esophagus, comprising a restriction device (a sphincter or a cuff) that can be adjusted. In one embodiment, the restriction device performs like an artificial sphincter that opens and closes the food passageway in the stomach. In an alternative embodiment, the restriction device comprises an adjustable cuff, a clamp, or a roller to bend or rotate the esophagus or stomach to close or almost close the junction between the stomach and esophagus.
- U.S. Pat. No. 4,246,893 describes a device and method for treating obesity by compressing the stomach and reducing its capacity using a single adjustable distensible device (e.g., a balloon) whose volume can be adjusted from an external port.
- U.S. Pat. No. 5,993,473 and WO 99/25418 describe a device and surgical method for treating obesity by decreasing the volume of the stomach by using a single expandable device placed inside the stomach cavity.
- U.S. Pat. No. 4,694,827 describes a device and method for controlling obesity by deterring ingestion of food using a single balloon that is placed inside the stomach.
- U.S. Publication No. 2002/0188354 describes a device for treating obesity by inserting an hourglass-shaped device into the junction between the stomach and the small bowel, which delays gastric emptying of food.
- U.S. Pat. No. 6,511,490 describes a device for the treatment of morbid obesity by restricting food passage in the stomach by placing an inflatable band around the stomach to create a pouch with a small opening adjacent to the esophagus. The inflatable band is secured and then inflated until the appropriate sized opening is achieved.
- We have discovered an apparatus and method for effectively treating morbid obesity in mammals, while minimizing the health risks associated with traditional surgery. The device reduces the gastric volume of the stomach and induces early satiety. The “gastric reduction assembly” comprises at least two or more expandable devices (e.g., balloons), each able to be independently inflated and adjusted from an external port. Each expandable device can be filled with a fluid (e.g., CO2, isotonic dextrose solution, isotonic saline solution, etc.) using a filling tube (e.g., a catheter), which can be easily accessed externally. In a preferred embodiment, the gastric reduction assembly is inserted percutaneously through the antero-lateral abdominal wall, and placed at a location exterior to the stomach body, avoiding an abdominal incision. Laparoscopic guidance, optionally, may be used to assist in placing the gastric reduction assembly near the stomach body. Once positioned near the stomach body, the gastric reduction assembly can be inflated to compress the volume of the stomach and effectively limit food intake. The gastric reduction assembly, with multiple expandable devices, minimizes the potential for post-implantation movement. The expandable devices have a size and shape to complement each other, such that they form a barrier when inflated that minimizes post implantation movement.
- To further minimize inferior migration, a subcutaneous anchor (e.g., a balloon or ring placed within the fatty layer between the skin and the abdominal wall), may be attached to the filling tubes to anchor the expandable devices to the abdominal wall. In addition, each expandable device may use an intragastric anchor (e.g., a collapsible fixation disc) to anchor the expandable device against the stomach body.
-
FIG. 1 illustrates a perspective view of one embodiment of the gastric reduction assembly, implanted in the peritoneal cavity around the stomach. -
FIG. 2 illustrates a front view of one embodiment of the gastric reduction assembly which has three expandable devices: two spherical-shaped and one crescent-shaped. - The invention provides a reliable, inexpensive method for treating obesity in mammals by reducing the volume of the stomach without abdominal surgery, thus reducing postoperative surgical complications. The gastric reduction assembly can provide either an intraperitoneal or an extraperitoneal method to compress the stomach. The placement depends on the surgeon's preference, and the physical condition and body habitus of the patient. In the intraperitoneal cavity, expandable devices can be placed either at a pregastric location (i.e., either anterior or anterolateral to the stomach) or a retrogastric location (i.e., either posterior or posterolateral to the stomach), or both. In the extraperitoneal cavity, the expandable devices can be placed in any of the anatomical compartments, spaces, or layers of the abdominal wall. Candidates for this minimally invasive procedure include patients with a BMI greater than 40, or patients with a BMI less than 40 and a debilitating disease related to the obesity such as diabetes, hypertension, and respiratory insufficiency.
- The basic design comprises a gastric reduction assembly having at least two or more expandable devices (e.g., balloons), each able to be adjusted and independently inflated. Each device can be inflated with a fluid (e.g., CO2, isotonic dextrose solution, isotonic saline solution, etc.) using a filling tube. The filling tube is accessed externally by way of an access device. To inflate each expandable device, the inlet of each filling tube is attached to a corresponding port, and fluid is injected into the inlet via a carrier (e.g., a hypodermic syringe). Fluid flows through the filling tube into each expandable device. Alternatively, fluid can be removed by reversing the process. The filling tubes may be locked together inside a single catheter or other large tubing such that only one tube crosses the abdominal wall to the access port.
- In a preferred embodiment, compression of the stomach is achieved using two or more spherical-shaped expandable devices to form a compressive barrier that reduces the volume of the stomach and minimizes post-implantation movement. Optionally, at least one crescent-shaped expandable device may be used to support the spherical-shaped expandable devices. The shape of the barrier formed by the multiple expandable devices may be adjusted to complement that of surrounding tissues and organs of the patient by changing the volume of the devices.
- To further minimize post-implantation movement, a subcutaneous anchor may be used to help anchor the expandable devices to the abdominal wall. In one embodiment, the subcutaneous anchor is a balloon-like device adapted to circumscribe the filling tubes subcutaneously or below the abdominal wall, at the muscular layer level. The volume of the subcutaneous anchor is adjusted by adding fluid. Alternatively, a ring lock may be placed around each filling tube at the muscular layer. In another embodiment, the expandable devices may be anchored to the stomach using an anchor e.g., a collapsible, fixation disc placed inside the stomach. One method of placement is to pass the intragastric anchor through a separate tube that crosses the expandable device and ends inside the stomach cavity. The tube can be accessed externally.
- The expandable devices can be implanted by passing through the skin and across the anterior abdominal wall via a larger tube to a predetermined implantation site. The expandable devices remain at the site, attached to filling tubes that can be accessed externally through a small single access port.
- The gastric reduction assembly has several advantages. First, the potential for incisional hernia and wound infections is substantially reduced, since no surgical incision of the abdominal wall is needed. The expandable devices are inserted through the skin and across the anterior abdominal wall via a small puncture. The access device for refilling or deflating the expandable devices is placed in the fatty layers of the abdomen, between the skin and the anterior abdominal muscles. Second, post-implantation movement is substantially reduced, almost eliminating a need to re-orient the expandable devices following implantation. Third, modifications (e.g., inflation, deflation, reorientation, or removal) may easily be done without surgery.
-
FIG. 1 illustrates a perspective view of one embodiment of thegastric reduction assembly 2, in accordance with the present invention. In this embodiment, the device comprises anaccess device 6, asubcutaneous anchor 8, and at least two or moreexpandable devices 4, each having anintragastric anchor 10 and a fillingtube 12. Multipleexpandable devices 4 are sized and shaped to complement each other such that when inflated, they cluster to form a compressive barrier capable of reducing the stomach volume and minimizing post-implantation movement. To adjustably inflate theexpandable devices 4 in the peritoneal cavity, fluid is injected into each fillingtube 12 of eachexpandable device 4 via theaccess device 6. - As shown in
FIG. 1 ,gastric reduction assembly 2 comprises three spherical-shaped expandable devices 4 (e.g., balloons) placed at a pregastric location. Alternatively,gastric reduction assembly 2 may comprise another number of expandable devices 4 (e.g., two, four, five, six, etc.). Optionally, at least one crescent-shapedexpandable device 13 may be used, as shown inFIG. 2 . This enhances the compressive barrier by forming a carrier ridge to support spherical-shapedexpandable devices 4.Expandable devices 4 can be made of any durable, distensible biocompatible material, such as rubber, latex, or polyurethane elastomer. - As shown in
FIG. 1 , each fillingtube 12 has an inlet at theaccess device 6 and an outlet to the interior of eachexpandable device 4 to allow for inflation with fluid. In an alternative embodiment, asingle filling tube 12 that has an inlet and outlet (not shown) for eachexpandable device 4 may be used. Fillingtubes 12 should be made of a durable, flexible, biocompatible material, such as TYGON® tubing, polyurethane, or other plastics. - As shown in
FIG. 1 ,subcutaneous anchor 8 is a distensible balloon-like device that circumscribes fillingtubes 12 within the fatty layer between the skin and abdominal wall or at a subperitoneal (i.e., below the abdominal wall) region to anchor theexpandable devices 4 to the abdominal wall. The balloon-like device is inflated via itsown filling tube 14. Alternatively,subcutaneous anchor 8 can be a ring lock (not shown) that joins all fillingtubes 12. When the ring lock is placed around fillingtubes 12 and advanced towards the abdominal wall, it forms an anchor against the muscular layer of the abdominal wall.Subcutaneous anchor 8 should be made of a durable, distensible biocompatible material, such as rubber, latex, or polyurethane elastomer. - As shown in
FIG. 1 ,intragastric anchor 10 is a collapsible, fixation disc which can be inserted through the stomach wall viatube 12 with asecond channel 16 that extends through eachexpandable device 4. The disc, once opened in the stomach, anchorsexpandable device 4 against the stomach. Onceintragastric anchor 10 is positioned within the stomach and unfolds, an attached suture may be pulled to form a snug fit between the exterior surface of the stomach body andexpandable devices 4. The size and shape ofintragastric anchor 10 is chosen to complement the inner surface of the stomach, and to provide a sufficient surface area (when unfolded) to preventintragastric anchor 10 from dislodging from the stomach when tension is applied.Intragastric anchor 10 should be made of a biocompatible material capable of shape memory, e.g., nitinol coated with polytetrafluoroethylene. - An
access device 6 comprises ports (not shown) to fillingtubes 12. The size and shape ofaccess device 6 is adapted to allow for a tight seal with fillingtubes 12 and a fluid carrier (e.g., a hypodermic syringe). The number of ports is determined by the number of tubes (12 and 14) that need to be accessed from the outside. - A preferred method of implanting the gastric reduction assembly is to go though the skin with a minimally invasive puncture. For example, a nasogastric tube (Bard, Covington, Ga.) is inserted into the stomach. The stomach is then inflated to better visualize it under fluoroscopy so that the proper location for an access site through the skin can be determined. The access site should be below the rib cage, near the gastric chamber. Once the access site is determined, a micropuncture needle (e.g., 22 g; Cook, Inc., Bloomington, Ind.) is inserted into the peritoneal cavity immediately in front of the anterior gastric wall. A microwire (e.g., 0.018 in; Cook, Inc., Bloomington, Ind.) is passed through the needle under fluoroscopic guidance and into the peritoneal cavity. Once the microwire reaches the peritoneal cavity, the micropuncture needle is removed over the wire.
- An access sheath (e.g., 6 French introducer; Cook, Inc., Bloomington, Ind.), a hollow tube that fits through the skin to form a temporary pathway to the peritoneal cavity, is then inserted over the microwire. The microwire is then removed, leaving the access sheath in place. A guidewire (e.g., 0.035 in stiff regular or hydrophilic; Boston Scientific, Natick, Massachusetts.) is then inserted through the access sheath to provide additional support. The opening in the abdominal wall is progressively dilated with dilators (Cook, Inc. Bloomington, Ind.) from 6-14 French. When the opening is sufficiently large, a larger access sheath (e.g., 14 Fr peel-away sheath; Cook, Inc. Bloomington, Indiana) is placed over the 0.035 in stiff guidewire, and the dilator and guidewire are removed. Air is then evacuated from the stomach through the nasogastric tube to provide space for the
gastric compression assembly 2. - Introducer tubes (e.g., catheters) containing expandable devices 4 (e.g., balloons) attached to filling
tubes 12 are inserted through the access sheath to a predetermined position near the stomach.Expandable devices 4 are released from the introducer tubes. Theexpandable devices 4 are then partially inflated sequentially near the stomach using a syringe to introduce fluid (e.g., CO2, isotonic saline solution, or isotonic dextrose solution) to theexpandable devices 4 through the fillingtubes 12. Introducer tubes are slowly withdrawn, and each fillingtube 12 is pulled until each partially inflatedexpandable device 4 contacts the abdominal wall. The access sheath is then removed, and a subcutaneous anchor 8 (e.g., a balloon or ring lock) is placed within the fatty layer between the skin and abdominal wall or the subperitoneal region (i.e., below the abdominal wall) to anchorexpandable devices 4.Expandable devices 4 are then inflated to a volume sufficient to compress the stomach, and fillingtubes 12 cut to an appropriate length. The inlets to fillingtubes 12 are then attached to the ports ofaccess device 6, andaccess device 6 is placed within the fatty layer between the skin and abdominal wall. The skin is then closed with sutures. - In an alternative embodiment, each
expandable device 4 is individually introduced to a preselected stomach compression site near the stomach and then anchored to the stomach, as described below. In this embodiment, fillingtube 12 to eachexpandable device 4 has at least two channels. Filingtube 12 is positioned to pass throughexpandable device 4 and abut the side ofexpandable device 4 that is near the stomach. One channel of fillingtube 12 has an opening that allows fluid to flow intoexpandable device 4 to inflate the device. The second channel of fillingtube 12 passes intact throughexpandable device 4 to the wall near the stomach. This channel allows anintragastric anchor 10 to be placed inside the stomach to help anchorexpandable device 4 as described below. Initially, a needle (e.g., an 18-gauge needle; Cook, Inc. Bloomington, Ind.) is passed through the access sheath to puncture the stomach wall. A contrast medium (e.g. gastrograffin) is then injected into the stomach to determine the needle's location. Once the location is determined, asuture 22 is attached tointragastric anchor 10, and the collapsed anchor is advanced through the needle into the stomach in a collapsed form using a stiff guidewire (e.g., 0.035 cm guidewire; Boston Scientific Corp, Natick, Mass.). Upon exiting the needle outlet within the stomach,intragastric anchor 10 resumes its disc-shaped configuration.Intragastric anchor 10 can be covered with a biocompatible material (e.g., GORTEX®, DACRON®, polyethylene or silicone) to help seal the gastric puncture site. The 18-gauge needle is then removed, while the stiff guidewire and suture remain attached to theintragastric anchor 10. Preferably,suture 22 is attached to the guidewire to allow for withdrawal. This process is repeated for each of the remainingexpandable devices 4. The stiff guidewire is then passed through the second channel of fillingtube 12 for eachexpandable device 4.Expandable devices 4 are then positioned at preselected stomach compression sites as described above. After verifying the compressive effects of eachexpandable device 4 on the gastric volume of the stomach, the stiff guidewires are disconnected fromsutures 22 and removed. Eachsuture 22 is then pulled back through the second channel of fillingtube 12 to anchor the device to the stomach wall. The access sheath is then removed, and fillingtubes 12 are cut to an appropriate length. The ends of each suture are pulled through the second channel and attached to accessdevice 6 to anchorexpandable devices 4.Expandable devices 4 can then be inflated or deflated throughaccess device 6, as necessary.Access device 6 is then placed within the fatty layer between the skin and the abdominal wall, and the skin is closed with sutures. - Clinical trials will initially involve testing two groups (a test and a control) of pigs weighing more than 50 kg. The gastric reduction assembly will be implanted into the test group. Once the gastric reduction assembly has been implanted, an upper gastrointestinal study (“UGI”) will be conducted with barium to check the gastric volume and passage of material through the stomach into the small intestine. The volume of the expandable devices will be adjusted in the test group based on the findings of the UGI. UGIs will be conducted at various intervals to check on the location and volume of the expandable devices. The two groups will be weighed weekly. After six months, the animals will be euthanized and the position of the gastric reduction assembly evaluated during necropsy. The data will be analyzed for differences in weight loss between the two groups.
- The complete disclosures of all references cited in this specification are hereby incorporated by reference. In the event of an otherwise irreconcilable conflict, however, the present specification shall control.
Claims (17)
1-105. (canceled)
106. A method of fastening a device to one wall of a gastrointestinal organ comprising:
passing said device through a patient's abdominal skin, wherein the device is in an undeployed configuration; passing an anchor through a patient's abdominal skin wherein said anchor is in an undeployed configuration;
deploying said device;
connecting said device and said anchor by a connector such that said anchor and device are fastened to a wall of said gastrointestinal organ by said connector, wherein said connector prevents said device and said anchor from moving apart; and
deploying said anchor to its deployed configuration;
wherein said device induces satiety in said patient.
107. The method of claim 106 , wherein said connector is a suture.
108. The method of claim 106 , wherein the gastrointestinal organ is the stomach, and said device is located outside the stomach.
109. The method of claim 108 , wherein said anchor is located at least partially inside the stomach, said device comprises an inflatable balloon and said connector is a suture.
110. The method of claim 106 , wherein said device comprises an inflatable balloon.
111. The method of claim 106 , wherein said anchor is covered with a mesh and said connector is a suture.
112. The method of claim 106 , wherein the gastrointestinal organ is the stomach, said device comprises an inflatable balloon, and said anchor is located outside of the stomach.
113. The method of claim 112 , wherein said device is located outside of the stomach.
114. The method of claim 106 , wherein the gastrointestinal organ is the stomach, said device is located outside of the stomach, said connector is a suture and said anchor is covered with a mesh.
115. A method of treating an obese patient comprising:
penetrating through the abdominal wall of a patient with a balloon adapted to track over a connector, wherein the balloon is expandable from a first undeployed configuration to a second deployed configuration, and wherein the balloon is fixed to a least two points inside the abdomen and wherein the balloon is further contoured to maintain contact with the gastrointestinal organ.
116. A method of placing a device to restrict flow of food in to the stomach of a patient comprising:
penetrating the abdominal wall of a patient;
contacting the stomach of the patient with a connector;
pushing an extragastric balloon through the abdominal wall while the extragastric balloon is in contact with the connector and while the extragastric balloon is undeployed and thence contacting the stomach of the patient with the balloon; and
fixing the extragastric balloon to an outer portion of the stomach.
117. The method of claim 116 , further comprising cutting the connector so that the residual of the connector remains in the abdominal cavity.
118. The method of claim 116 , further comprising cutting the connector so that the residual of the connector traverses at least a part of the abdominal wall.
119. The method of claim 118 , further comprising attaching an access port to the connector operable to inflate or deflate the extragastric balloon.
120. The method of claim 116 , further comprising visualizing the connector under fluoroscopy.
121. The method of claim 116 wherein said method is performed laparoscopically.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/458,759 US20120215249A1 (en) | 2003-08-13 | 2012-04-27 | Compressive Device for Percutaneous Treatment of Obesity |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49469803P | 2003-08-13 | 2003-08-13 | |
PCT/US2004/024612 WO2005018417A2 (en) | 2003-08-13 | 2004-07-30 | Compressive device for percutaneous treatment of obesity |
US10/567,199 US8192455B2 (en) | 2003-08-13 | 2004-07-30 | Compressive device for percutaneous treatment of obesity |
US13/458,759 US20120215249A1 (en) | 2003-08-13 | 2012-04-27 | Compressive Device for Percutaneous Treatment of Obesity |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/024612 Division WO2005018417A2 (en) | 2003-08-13 | 2004-07-30 | Compressive device for percutaneous treatment of obesity |
US11/567,199 Division US7567127B2 (en) | 2006-09-20 | 2006-12-05 | Automatic-gain control circuit |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120215249A1 true US20120215249A1 (en) | 2012-08-23 |
Family
ID=34215893
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/567,199 Expired - Fee Related US8192455B2 (en) | 2003-08-13 | 2004-07-30 | Compressive device for percutaneous treatment of obesity |
US13/458,759 Abandoned US20120215249A1 (en) | 2003-08-13 | 2012-04-27 | Compressive Device for Percutaneous Treatment of Obesity |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/567,199 Expired - Fee Related US8192455B2 (en) | 2003-08-13 | 2004-07-30 | Compressive device for percutaneous treatment of obesity |
Country Status (5)
Country | Link |
---|---|
US (2) | US8192455B2 (en) |
EP (1) | EP1670525A4 (en) |
AU (2) | AU2004266574B2 (en) |
CA (1) | CA2540653C (en) |
WO (1) | WO2005018417A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110106129A1 (en) * | 2004-10-27 | 2011-05-05 | Michael Gertner | Methods and devices to treat obesity |
US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
US10137023B2 (en) | 2012-09-14 | 2018-11-27 | Medibotics Llc | Colonnade (TM) expandable intragastric food flow lumen device |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2540653C (en) | 2003-08-13 | 2012-09-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compressive device for percutaneous treatment of obesity |
US7255675B2 (en) | 2004-03-23 | 2007-08-14 | Michael Gertner | Devices and methods to treat a patient |
US7841978B2 (en) * | 2004-03-23 | 2010-11-30 | Michael Gertner | Methods and devices for to treatment of obesity |
EP1744804A4 (en) * | 2004-05-03 | 2009-11-04 | Fulfillium Inc | Method and system for gastric volume control |
US8070807B2 (en) | 2004-11-19 | 2011-12-06 | Fulfillium, Inc. | Wireless breach detection |
US9456915B2 (en) | 2004-11-19 | 2016-10-04 | Fulfilium, Inc. | Methods, devices, and systems for obesity treatment |
US7785291B2 (en) | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US7699863B2 (en) | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US9345604B2 (en) | 2005-05-02 | 2016-05-24 | Almuhannad Alfrhan | Percutaneous intragastric balloon device and method |
CA2618371A1 (en) * | 2005-08-11 | 2007-02-15 | Adrian Paz | Implantable device for obesity prevention |
US20090275972A1 (en) * | 2006-04-19 | 2009-11-05 | Shuji Uemura | Minimally-invasive methods for implanting obesity treatment devices |
US8342183B2 (en) | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US20090287227A1 (en) * | 2006-04-19 | 2009-11-19 | Newell Matthew B | Minimally invasive ,methods for implanting obesity treatment devices |
US20090281376A1 (en) * | 2006-04-19 | 2009-11-12 | Acosta Pablo G | Devices, system and methods for minimally invasive abdominal surgical procedures |
US8070768B2 (en) * | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8398668B2 (en) | 2006-04-19 | 2013-03-19 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US20090281563A1 (en) * | 2006-04-19 | 2009-11-12 | Newell Matthew B | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US20090281500A1 (en) * | 2006-04-19 | 2009-11-12 | Acosta Pablo G | Devices, system and methods for minimally invasive abdominal surgical procedures |
US8187297B2 (en) | 2006-04-19 | 2012-05-29 | Vibsynt, Inc. | Devices and methods for treatment of obesity |
US7976554B2 (en) * | 2006-04-19 | 2011-07-12 | Vibrynt, Inc. | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US20090281386A1 (en) * | 2006-04-19 | 2009-11-12 | Acosta Pablo G | Devices, system and methods for minimally invasive abdominal surgical procedures |
US8556925B2 (en) | 2007-10-11 | 2013-10-15 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US20090272388A1 (en) * | 2006-04-19 | 2009-11-05 | Shuji Uemura | Minimally-invasive methods for implanting obesity treatment devices |
US8585733B2 (en) | 2006-04-19 | 2013-11-19 | Vibrynt, Inc | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
EP2066272A2 (en) * | 2006-12-28 | 2009-06-10 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8926648B2 (en) * | 2007-02-13 | 2015-01-06 | Brian Charles Weiner | Multi-method and multi-apparatus for treating obesity |
US20090192541A1 (en) * | 2008-01-28 | 2009-07-30 | Ethicon Endo-Surgery, Inc. | Methods and devices for predicting performance of a gastric restriction system |
WO2009096857A1 (en) * | 2008-01-29 | 2009-08-06 | Milux Holding Sa | A device, system and method for treating obesity |
US20100114144A1 (en) * | 2008-10-30 | 2010-05-06 | Albrecht Thomas E | Intra-gastric satiety creation device with data handling devices and methods |
US20100114148A1 (en) * | 2008-10-30 | 2010-05-06 | Albrecht Thomas E | Devices and methods for adjusting a satiation and satiety-inducing implanted device |
US20100114143A1 (en) * | 2008-10-30 | 2010-05-06 | Albrecht Thomas E | Wearable elements for intra-gastric satiety creations systems |
US20100114141A1 (en) * | 2008-10-30 | 2010-05-06 | Albrecht Thomas E | Optimizing the operation of an intra-gastric satiety creation device |
US20100114146A1 (en) * | 2008-10-30 | 2010-05-06 | Albrecht Thomas E | Methods and devices for predicting intra-gastric satiety and satiation creation device system performance |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US9326760B2 (en) * | 2011-03-28 | 2016-05-03 | Prabhat Kumar Ahluwalia | Organ retractor |
US8382775B1 (en) | 2012-01-08 | 2013-02-26 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US9314362B2 (en) | 2012-01-08 | 2016-04-19 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US10507127B2 (en) | 2012-06-07 | 2019-12-17 | Epitomee Medical Ltd. | Expandable device |
US20140018836A1 (en) * | 2012-07-13 | 2014-01-16 | Top-Bound Enterprise Co., Ltd | Endo-Safe-Bag-Gasless support system |
BR112016012615B1 (en) | 2013-12-05 | 2023-02-07 | Epitomee Medical Ltd | SYSTEMS, AND KIT |
US10864367B2 (en) | 2015-02-24 | 2020-12-15 | Elira, Inc. | Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions |
US10376145B2 (en) | 2015-02-24 | 2019-08-13 | Elira, Inc. | Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch |
US10765863B2 (en) | 2015-02-24 | 2020-09-08 | Elira, Inc. | Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy |
US20220062621A1 (en) | 2015-02-24 | 2022-03-03 | Elira, Inc. | Electrical Stimulation-Based Weight Management System |
EP3261712B1 (en) | 2015-02-24 | 2024-04-03 | Elira, Inc. | System for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch |
US9956393B2 (en) | 2015-02-24 | 2018-05-01 | Elira, Inc. | Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch |
US10335302B2 (en) | 2015-02-24 | 2019-07-02 | Elira, Inc. | Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions |
EP3160147A1 (en) | 2015-10-19 | 2017-04-26 | Thomson Licensing | Method for fast channel change, corresponding arrangement and device |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
KR102163651B1 (en) * | 2018-12-24 | 2020-10-08 | 박용희 | using buoy system for dirt |
WO2021158802A1 (en) * | 2020-02-04 | 2021-08-12 | Silin Douglas D | Compression device and related methods for using the same |
Family Cites Families (235)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2734299A (en) * | 1956-02-14 | Igudolph | ||
US233475A (en) | 1880-10-19 | l vandermark | ||
US659422A (en) | 1900-06-12 | 1900-10-09 | George W Shidler | Surgical instrument. |
US789467A (en) * | 1903-06-12 | 1905-05-09 | Stillman A West | Method of tying knots. |
US780392A (en) * | 1903-09-14 | 1905-01-17 | Brown Straw Binder Company | Straw-bundle tie. |
US1461524A (en) | 1922-12-05 | 1923-07-10 | Ball And Socket Mfg Company | Cuff button |
US2579192A (en) | 1950-08-15 | 1951-12-18 | George H Sciaroni | Suturing instrument |
US2697624A (en) | 1951-11-03 | 1954-12-21 | John A Thomas | Portable knot tying device |
US2646298A (en) | 1952-07-15 | 1953-07-21 | Joseph C Leary | Method of knot tying |
US2825592A (en) * | 1954-01-06 | 1958-03-04 | Semple James Mckenzie | Portable knot tying device for smooth filaments |
US3326586A (en) * | 1965-07-09 | 1967-06-20 | Robert M Frost | Snell knot tying tool |
US3470834A (en) | 1968-03-08 | 1969-10-07 | Dennison Mfg Co | Fastener attaching device |
FR1574897A (en) * | 1968-05-27 | 1969-07-18 | ||
US3521918A (en) | 1968-08-14 | 1970-07-28 | Richard L Hammond | Fishline knotting fixture and cutter |
US3675639A (en) | 1970-05-11 | 1972-07-11 | Hugo S Cimber | Device for and method of temporary sterilizing a female |
US3664435A (en) * | 1970-11-09 | 1972-05-23 | Worthington Corp Worthington C | Hydraulic hammer with automatic stopping action |
US3713680A (en) * | 1971-02-09 | 1973-01-30 | S Pagano | Knot typing device for barrel knots |
US3756638A (en) | 1972-02-22 | 1973-09-04 | L Stockberger | Knot tyer |
US3873140A (en) * | 1973-10-15 | 1975-03-25 | Moodus Sports Products | Fish hook holder and knot tying device |
US3931667A (en) * | 1974-05-08 | 1976-01-13 | Dennison Manufacturing Company | Interlocking attachment device |
US3976079A (en) | 1974-08-01 | 1976-08-24 | Samuels Peter B | Securing devices for sutures |
US4006747A (en) | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
US4060089A (en) | 1975-09-03 | 1977-11-29 | United States Surgical Corporation | Surgical fastening method and device therefor |
US4006767A (en) * | 1975-10-08 | 1977-02-08 | The Firestone Tire & Rubber Company | Pneumatic tires |
US4133315A (en) * | 1976-12-27 | 1979-01-09 | Berman Edward J | Method and apparatus for reducing obesity |
US4246893A (en) * | 1978-07-05 | 1981-01-27 | Daniel Berson | Inflatable gastric device for treating obesity |
US4210148A (en) | 1978-11-03 | 1980-07-01 | Stivala Oscar G | Retention suture system |
DE2853289C2 (en) | 1978-12-09 | 1980-12-18 | B. Braun Melsungen Ag, 3508 Melsungen | Button for surgical use |
US4472226A (en) | 1979-10-03 | 1984-09-18 | Minnesota Mining And Manufacturing Company | Silicone gel filled prosthesis |
US4328805A (en) * | 1980-10-03 | 1982-05-11 | Akopov Ernest M | Method of suturing the organs of the gastrointestinal tract |
US4416267A (en) | 1981-12-10 | 1983-11-22 | Garren Lloyd R | Method and apparatus for treating obesity |
US4899747A (en) * | 1981-12-10 | 1990-02-13 | Garren Lloyd R | Method and appartus for treating obesity |
US6656182B1 (en) | 1982-05-20 | 2003-12-02 | John O. Hayhurst | Tissue manipulation |
US4458681A (en) | 1982-06-10 | 1984-07-10 | Hopkins Donald A | Stomach clamp for and method of proximal gastric partitioning |
US4823794A (en) * | 1982-07-12 | 1989-04-25 | Pierce William S | Surgical pledget |
US4485805A (en) | 1982-08-24 | 1984-12-04 | Gunther Pacific Limited Of Hong Kong | Weight loss device and method |
US4493323A (en) * | 1982-12-13 | 1985-01-15 | University Of Iowa Research Foundation | Suturing device and method for using same |
US4558699A (en) | 1983-01-03 | 1985-12-17 | Bashour Samuel B | Method of and apparatus for restricting the passage of food through the stomach |
US4592342A (en) | 1983-05-02 | 1986-06-03 | Salmasian Samuel S | Method for appetite suppression and weight loss maintenance and device |
US4621640A (en) | 1984-01-09 | 1986-11-11 | Mulhollan James S | Mechanical needle carrier and method for its use |
US4750492A (en) | 1985-02-27 | 1988-06-14 | Richards Medical Company | Absorbable suture apparatus, method and installer |
US4955913A (en) | 1985-03-28 | 1990-09-11 | Robinson Walter C | Surgical tie |
US4723547A (en) * | 1985-05-07 | 1988-02-09 | C. R. Bard, Inc. | Anti-obesity balloon placement system |
US4592339A (en) * | 1985-06-12 | 1986-06-03 | Mentor Corporation | Gastric banding device |
US4696288A (en) | 1985-08-14 | 1987-09-29 | Kuzmak Lubomyr I | Calibrating apparatus and method of using same for gastric banding surgery |
US4669473A (en) | 1985-09-06 | 1987-06-02 | Acufex Microsurgical, Inc. | Surgical fastener |
US4705040A (en) | 1985-11-18 | 1987-11-10 | Medi-Tech, Incorporated | Percutaneous fixation of hollow organs |
USRE34021E (en) | 1985-11-18 | 1992-08-04 | Abbott Laboratories | Percutaneous fixation of hollow organs |
US4694827A (en) | 1986-01-14 | 1987-09-22 | Weiner Brian C | Inflatable gastric device for treating obesity and method of using the same |
US4803985A (en) * | 1986-02-14 | 1989-02-14 | Hill Carl W | Gastroplasty method |
US4738255A (en) * | 1986-04-07 | 1988-04-19 | Biotron Labs, Inc. | Suture anchor system |
US4739758A (en) * | 1986-05-19 | 1988-04-26 | Criticare Systems, Inc. | Apparatus for stomach cavity reduction |
US5123914A (en) | 1986-05-19 | 1992-06-23 | Cook Incorporated | Visceral anchor for visceral wall mobilization |
US4714281A (en) | 1987-01-02 | 1987-12-22 | Peck Richard M | Device and method for tying a twisted clinch knot |
US4744364A (en) * | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US4898156A (en) * | 1987-05-18 | 1990-02-06 | Mitek Surgical Products, Inc. | Suture anchor |
US5084061A (en) * | 1987-09-25 | 1992-01-28 | Gau Fred C | Intragastric balloon with improved valve locating means |
US5304197A (en) | 1988-10-04 | 1994-04-19 | Cordis Corporation | Balloons for medical devices and fabrication thereof |
US5002550A (en) * | 1989-06-06 | 1991-03-26 | Mitek Surgical Products, Inc. | Suture anchor installation tool |
JP2984056B2 (en) * | 1989-09-08 | 1999-11-29 | ボストン サイエンティフィック コーポレイション | Physiological low pressure angioplasty |
US5454365A (en) * | 1990-11-05 | 1995-10-03 | Bonutti; Peter M. | Mechanically expandable arthroscopic retractors |
US5041129A (en) | 1990-07-02 | 1991-08-20 | Acufex Microsurgical, Inc. | Slotted suture anchor and method of anchoring a suture |
US5269809A (en) | 1990-07-02 | 1993-12-14 | American Cyanamid Company | Locking mechanism for use with a slotted suture anchor |
US5033481A (en) | 1990-10-12 | 1991-07-23 | Inamed Development Company | Intraoperative or interoperative longitudinal tissue expander |
US5129912B2 (en) | 1991-01-07 | 2000-01-11 | Urohealth Systems Inc | Device and method for applying suture |
US5188104A (en) * | 1991-02-01 | 1993-02-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
US5100421A (en) * | 1991-02-05 | 1992-03-31 | Cyprus Endosurgical Tools, Inc. | Christoudias curved needle suture assembly |
US5112310A (en) * | 1991-02-06 | 1992-05-12 | Grobe James L | Apparatus and methods for percutaneous endoscopic gastrostomy |
US5405352A (en) * | 1991-04-09 | 1995-04-11 | Weston; Peter V. | Suture knot, method for its formation and use, and knot forming apparatus |
US5217470A (en) | 1991-04-29 | 1993-06-08 | Weston Peter V | Apparatuses and methods for formation and use of a slipknot as a surgical suture knot |
US5258015A (en) | 1991-05-03 | 1993-11-02 | American Cyanamid Company | Locking filament caps |
US5234454A (en) | 1991-08-05 | 1993-08-10 | Akron City Hospital | Percutaneous intragastric balloon catheter and method for controlling body weight therewith |
US5151086A (en) * | 1991-10-22 | 1992-09-29 | The Regents Of The University Of California | Laparoscopic tube placement method |
US5259399A (en) | 1992-03-02 | 1993-11-09 | Alan Brown | Device and method of causing weight loss using removable variable volume intragastric bladder |
AU4033893A (en) | 1992-04-24 | 1993-11-29 | Polymer Technology Group, Inc., The | Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range |
IT1260485B (en) | 1992-05-29 | 1996-04-09 | PROCEDURE AND DEVICE FOR THE TREATMENT OF THE OBESITY OF A PATIENT | |
US5246456A (en) | 1992-06-08 | 1993-09-21 | Wilkinson Lawrence H | Fenestrated gastric pouch |
US5292344A (en) * | 1992-07-10 | 1994-03-08 | Douglas Donald D | Percutaneously placed electrical gastrointestinal pacemaker stimulatory system, sensing system, and pH monitoring system, with optional delivery port |
US5364408A (en) | 1992-09-04 | 1994-11-15 | Laurus Medical Corporation | Endoscopic suture system |
US5334200A (en) | 1993-03-02 | 1994-08-02 | Lanny L. Johnson | Suture knot making device and method for use |
US6162234A (en) | 1993-03-23 | 2000-12-19 | Freedland; Yosef | Adjustable button cinch anchor orthopedic fastener |
US5549621A (en) | 1993-05-14 | 1996-08-27 | Byron C. Sutherland | Apparatus and method for performing vertical banded gastroplasty |
US5601604A (en) * | 1993-05-27 | 1997-02-11 | Inamed Development Co. | Universal gastric band |
US5716368A (en) * | 1993-06-02 | 1998-02-10 | General Surgical Innovations, Inc. | Knotmaker with curved elongate member used in tying a ligature |
US5472446A (en) | 1993-06-02 | 1995-12-05 | De La Torre; Roger A. | Surgical instrument for tying a knot in a length of suture at a remote location |
US5391182A (en) * | 1993-08-03 | 1995-02-21 | Origin Medsystems, Inc. | Apparatus and method for closing puncture wounds |
US5354271A (en) | 1993-08-05 | 1994-10-11 | Voda Jan K | Vascular sheath |
US5445608A (en) | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
US5507754A (en) * | 1993-08-20 | 1996-04-16 | United States Surgical Corporation | Apparatus and method for applying and adjusting an anchoring device |
US5536273A (en) * | 1993-12-09 | 1996-07-16 | Lehrer; Theodor | Apparatus and method of extracorporeally applying and locking laparoscopic suture and loop ligatures |
US6045496A (en) * | 1994-04-15 | 2000-04-04 | Allegheny-Singer Research Institute | Occluder device and method of making |
US5545178A (en) | 1994-04-29 | 1996-08-13 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
US5470337A (en) | 1994-05-17 | 1995-11-28 | Moss; Gerald | Surgical fastener |
US5573540A (en) | 1994-07-18 | 1996-11-12 | Yoon; Inbae | Apparatus and method for suturing an opening in anatomical tissue |
US5545171A (en) | 1994-09-22 | 1996-08-13 | Vidamed, Inc. | Anastomosis catheter |
US5480406A (en) * | 1994-10-07 | 1996-01-02 | United States Surgical Corporation | Method of employing surgical suturing apparatus to tie knots |
US5554162A (en) | 1994-12-02 | 1996-09-10 | Delange; Gregory S. | Method and device for surgically joining luminal structures |
US5634936A (en) | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US6102922A (en) | 1995-09-22 | 2000-08-15 | Kirk Promotions Limited | Surgical method and device for reducing the food intake of patient |
US5647836A (en) | 1995-09-28 | 1997-07-15 | Blake, Iii; Joseph W. | Method and means for treating female urinary incontinence |
US5626614A (en) * | 1995-12-22 | 1997-05-06 | Applied Medical Resources Corporation | T-anchor suturing device and method for using same |
US5690691A (en) | 1996-05-08 | 1997-11-25 | The Center For Innovative Technology | Gastro-intestinal pacemaker having phased multi-point stimulation |
US6013053A (en) * | 1996-05-17 | 2000-01-11 | Qlt Photo Therapeutics Inc. | Balloon catheter for photodynamic therapy |
US6080160A (en) | 1996-12-04 | 2000-06-27 | Light Sciences Limited Partnership | Use of shape memory alloy for internally fixing light emitting device at treatment site |
US5961440A (en) | 1997-01-02 | 1999-10-05 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US5846254A (en) | 1997-04-08 | 1998-12-08 | Ethicon Endo-Surgery, Inc. | Surgical instrument for forming a knot |
US6120539A (en) | 1997-05-01 | 2000-09-19 | C. R. Bard Inc. | Prosthetic repair fabric |
US5938669A (en) | 1997-05-07 | 1999-08-17 | Klasamed S.A. | Adjustable gastric banding device for contracting a patient's stomach |
US6071292A (en) | 1997-06-28 | 2000-06-06 | Transvascular, Inc. | Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures |
AUPO787897A0 (en) | 1997-07-14 | 1997-08-07 | Cardiac Crc Nominees Pty Limited | Silicon-containing chain extenders |
EP0996482B1 (en) * | 1997-07-16 | 2007-02-14 | Metacure NV | Smooth muscle controller |
US5993473A (en) | 1997-11-19 | 1999-11-30 | Chan; Yung C. | Expandable body device for the gastric cavity and method |
US5931788A (en) | 1997-12-05 | 1999-08-03 | Keen; Richard R. | Method and apparatus for imaging internal organs and vascular structures through the gastrointestinal wall |
AUPP268898A0 (en) | 1998-03-31 | 1998-04-23 | Cardiac Crc Nominees Pty Limited | High modulus polyurethane compositions |
US5971447A (en) | 1998-04-15 | 1999-10-26 | Steck, Iii; William F | Fisherman's knot tying device |
US6143006A (en) | 1998-04-18 | 2000-11-07 | Chan; Kwan-Ho | Apparatus and method for tying and tensioning knots |
US6113609A (en) * | 1998-05-26 | 2000-09-05 | Scimed Life Systems, Inc. | Implantable tissue fastener and system for treating gastroesophageal reflux disease |
US5951590A (en) | 1998-06-09 | 1999-09-14 | Goldfarb; Michael A. | Soft tissue suture anchor |
US6488691B1 (en) | 1998-06-24 | 2002-12-03 | Brendan J. Carroll | Laparascopic incision closure device |
US6067991A (en) * | 1998-08-13 | 2000-05-30 | Forsell; Peter | Mechanical food intake restriction device |
US6900055B1 (en) * | 1998-10-28 | 2005-05-31 | Cellon S.A. | Preparation of porous silicone rubber for growing cells or living tissue |
US6097984A (en) | 1998-11-25 | 2000-08-01 | Medtronic, Inc. | System and method of stimulation for treating gastro-esophageal reflux disease |
ATE324072T1 (en) | 1998-12-30 | 2006-05-15 | Ethicon Inc | THREAD SECURING DEVICE |
US6312405B1 (en) * | 1999-02-02 | 2001-11-06 | American Medical Systems, Inc. | Self-sealing detachable balloon |
US8137364B2 (en) | 2003-09-11 | 2012-03-20 | Abbott Laboratories | Articulating suturing device and method |
US6684104B2 (en) * | 1999-04-14 | 2004-01-27 | Transneuronix, Inc. | Gastric stimulator apparatus and method for installing |
AU4327599A (en) | 1999-06-02 | 2000-12-28 | Bioenterics Corporation | Pelvic displacement prosthesis for radioprotection of the small bowel |
US6494888B1 (en) | 1999-06-22 | 2002-12-17 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6821285B2 (en) | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6506196B1 (en) * | 1999-06-22 | 2003-01-14 | Ndo Surgical, Inc. | Device and method for correction of a painful body defect |
US6835200B2 (en) | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US6663639B1 (en) | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US7618426B2 (en) | 2002-12-11 | 2009-11-17 | Usgi Medical, Inc. | Apparatus and methods for forming gastrointestinal tissue approximations |
US7160312B2 (en) * | 1999-06-25 | 2007-01-09 | Usgi Medical, Inc. | Implantable artificial partition and methods of use |
US7416554B2 (en) | 2002-12-11 | 2008-08-26 | Usgi Medical Inc | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US20040122456A1 (en) | 2002-12-11 | 2004-06-24 | Saadat Vahid C. | Methods and apparatus for gastric reduction |
US6206895B1 (en) | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
AU769270B2 (en) | 1999-08-12 | 2004-01-22 | Obtech Medical Ag | Stoma opening forming apparatus |
US20030208212A1 (en) | 1999-12-07 | 2003-11-06 | Valerio Cigaina | Removable gastric band |
US6600953B2 (en) | 2000-12-11 | 2003-07-29 | Impulse Dynamics N.V. | Acute and chronic electrical signal therapy for obesity |
US20010010005A1 (en) | 2000-01-24 | 2001-07-26 | Kammerer Gene W. | Meniscal repair device |
US6475136B1 (en) | 2000-02-14 | 2002-11-05 | Obtech Medical Ag | Hydraulic heartburn and reflux treatment |
MXPA00001922A (en) | 2000-02-24 | 2002-03-08 | De Hayos Garza Andres | Percutaneous intra-gastric balloon catheter for obesity treatment. |
JP2003533257A (en) * | 2000-05-15 | 2003-11-11 | シー・アール・バード・インク | Endoscope accessory mounting mechanism |
US7033373B2 (en) * | 2000-11-03 | 2006-04-25 | Satiety, Inc. | Method and device for use in minimally invasive placement of space-occupying intragastric devices |
US20020161382A1 (en) | 2001-03-29 | 2002-10-31 | Neisz Johann J. | Implant inserted without bone anchors |
US6770076B2 (en) | 2001-02-12 | 2004-08-03 | Opus Medical, Inc. | Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device |
EP1366716B1 (en) * | 2001-03-09 | 2005-04-27 | José Rafael Garza Alvarez | Intragastric balloon assembly |
US6535764B2 (en) * | 2001-05-01 | 2003-03-18 | Intrapace, Inc. | Gastric treatment and diagnosis device and method |
US6558400B2 (en) * | 2001-05-30 | 2003-05-06 | Satiety, Inc. | Obesity treatment tools and methods |
US20020188354A1 (en) | 2001-06-12 | 2002-12-12 | Peghini Paolo Lino | Device to treat obesity by obstructing gastric outlet |
US6511490B2 (en) * | 2001-06-22 | 2003-01-28 | Antoine Jean Henri Robert | Gastric banding device and method |
US6627206B2 (en) * | 2001-07-25 | 2003-09-30 | Greg A. Lloyd | Method and apparatus for treating obesity and for delivering time-released medicaments |
US6675809B2 (en) * | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US6773436B2 (en) | 2001-09-28 | 2004-08-10 | Depuy Mitek, Inc. | Absorbable bone anchor |
ITMI20012046A1 (en) | 2001-10-03 | 2003-04-03 | Sintesi S R L | ANTI-REFLUX GASTRO-ESOPHAGEAL VALVE PROSTHESIS |
US6755869B2 (en) | 2001-11-09 | 2004-06-29 | Boston Scientific Corporation | Intragastric prosthesis for the treatment of morbid obesity |
FR2834202B1 (en) * | 2001-12-28 | 2004-03-19 | Cie Euro Etude Rech Paroscopie | MULTI-POCKET INTRA-GASTRIC BALLOON, SURGICAL EXPANSION DEVICE FOR SAID BALLOON AND MANUFACTURING METHOD THEREOF |
US6790213B2 (en) | 2002-01-07 | 2004-09-14 | C.R. Bard, Inc. | Implantable prosthesis |
US7402166B2 (en) | 2002-02-15 | 2008-07-22 | A&P Feigl Family Limited Partnership | Devices and methods for positioning sutures |
WO2003095015A1 (en) | 2002-05-09 | 2003-11-20 | Applied Medical Resources Corporation | Balloon system and methods for treating obesity |
CA2485461C (en) | 2002-05-17 | 2011-01-04 | Tyco Healthcare Group, Lp | Endoscopic organ retraction system and method of using the same |
US6773440B2 (en) * | 2002-07-02 | 2004-08-10 | Satiety, Inc. | Method and device for use in tissue approximation and fixation |
US6746460B2 (en) * | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
US7338433B2 (en) * | 2002-08-13 | 2008-03-04 | Allergan, Inc. | Remotely adjustable gastric banding method |
US7033384B2 (en) * | 2002-08-30 | 2006-04-25 | Satiety, Inc. | Stented anchoring of gastric space-occupying devices |
US6981978B2 (en) * | 2002-08-30 | 2006-01-03 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
AU2003272288A1 (en) * | 2002-09-06 | 2004-03-29 | C.R. Bard, Inc. | Tissue capturing devices |
WO2004021894A1 (en) * | 2002-09-09 | 2004-03-18 | Brian Kelleher | Device and method for endoluminal therapy |
DE10243132B4 (en) | 2002-09-17 | 2006-09-14 | Biocer Entwicklungs Gmbh | Anti-infective, biocompatible titanium oxide coatings for implants and methods of making them |
US7070591B2 (en) * | 2002-09-17 | 2006-07-04 | Transoma Medical, Inc. | Vascular access port with physiological sensor |
US20040068224A1 (en) * | 2002-10-02 | 2004-04-08 | Couvillon Lucien Alfred | Electroactive polymer actuated medication infusion pumps |
US7037344B2 (en) * | 2002-11-01 | 2006-05-02 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US7794447B2 (en) * | 2002-11-01 | 2010-09-14 | Valentx, Inc. | Gastrointestinal sleeve device and methods for treatment of morbid obesity |
US9060844B2 (en) * | 2002-11-01 | 2015-06-23 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US6656194B1 (en) | 2002-11-05 | 2003-12-02 | Satiety, Inc. | Magnetic anchoring devices |
US20040133147A1 (en) * | 2002-11-06 | 2004-07-08 | Woo Sang Hoon | Intestinal bypass device to treat obesity |
US7016730B2 (en) * | 2002-11-15 | 2006-03-21 | Cardiac Pacemakers, Inc. | Method of operating implantable medical devices to prolong battery life |
US7942898B2 (en) | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Delivery systems and methods for gastric reduction |
US7167750B2 (en) * | 2003-02-03 | 2007-01-23 | Enteromedics, Inc. | Obesity treatment with electrically induced vagal down regulation |
US7291160B2 (en) * | 2003-03-17 | 2007-11-06 | Delegge Rebecca | Intragastric catheter |
US20060058829A1 (en) * | 2003-03-19 | 2006-03-16 | Sampson Douglas C | Intragastric volume-occupying device |
US7320701B2 (en) | 2003-06-02 | 2008-01-22 | Linvatec Corporation | Push-in suture anchor, insertion tool, and method for inserting a push-in suture anchor |
US7862546B2 (en) | 2003-06-16 | 2011-01-04 | Ethicon Endo-Surgery, Inc. | Subcutaneous self attaching injection port with integral moveable retention members |
BR0302240B8 (en) | 2003-06-24 | 2013-02-19 | semi-stationary balloon in the gastric antrum with anchor rod for weight loss induction in humans. | |
CA2540653C (en) | 2003-08-13 | 2012-09-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compressive device for percutaneous treatment of obesity |
US7144400B2 (en) | 2003-10-01 | 2006-12-05 | Ethicon Endo-Surgery, Inc. | Gastric band introduction device |
US20050247320A1 (en) | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
US20050131325A1 (en) | 2003-12-16 | 2005-06-16 | How-Lun Chen | Flexible injection port |
US20050197687A1 (en) | 2004-03-02 | 2005-09-08 | Masoud Molaei | Medical devices including metallic films and methods for making same |
US20080147002A1 (en) | 2004-03-23 | 2008-06-19 | Michael Eric Gertner | Obesity treatment systems |
US20050228415A1 (en) | 2004-03-23 | 2005-10-13 | Michael Gertner | Methods and devices for percutaneous, non-laparoscopic treatment of obesity |
US20060264699A1 (en) | 2004-10-27 | 2006-11-23 | Michael Gertner | Extragastric minimally invasive methods and devices to treat obesity |
US7255675B2 (en) | 2004-03-23 | 2007-08-14 | Michael Gertner | Devices and methods to treat a patient |
US20070233170A1 (en) | 2004-03-23 | 2007-10-04 | Michael Gertner | Extragastric Balloon |
US20080071306A1 (en) * | 2004-03-23 | 2008-03-20 | Michael Gertner | Extragastric Balloon With Attachment Tabs |
US7946976B2 (en) | 2004-03-23 | 2011-05-24 | Michael Gertner | Methods and devices for the surgical creation of satiety and biofeedback pathways |
WO2006049725A2 (en) | 2004-03-23 | 2006-05-11 | Minimus Surgical Systems | Surgical systems and devices to enhance gastric restriction therapies |
US20060195139A1 (en) | 2004-03-23 | 2006-08-31 | Michael Gertner | Extragastric devices and methods for gastroplasty |
US7841978B2 (en) * | 2004-03-23 | 2010-11-30 | Michael Gertner | Methods and devices for to treatment of obesity |
WO2005105003A1 (en) | 2004-04-26 | 2005-11-10 | Synecor, Llc | Restrictive and/or obstructive implant for inducing weight loss |
US20050240155A1 (en) | 2004-04-27 | 2005-10-27 | Conlon Sean P | Surgically implantable injection port having a centered catheter connection tube |
EP1744804A4 (en) | 2004-05-03 | 2009-11-04 | Fulfillium Inc | Method and system for gastric volume control |
US7112186B2 (en) | 2004-05-26 | 2006-09-26 | Shah Tilak M | Gastro-occlusive device |
US7374565B2 (en) * | 2004-05-28 | 2008-05-20 | Ethicon Endo-Surgery, Inc. | Bi-directional infuser pump with volume braking for hydraulically controlling an adjustable gastric band |
US7390294B2 (en) | 2004-05-28 | 2008-06-24 | Ethicon Endo-Surgery, Inc. | Piezo electrically driven bellows infuser for hydraulically controlling an adjustable gastric band |
US7351240B2 (en) | 2004-05-28 | 2008-04-01 | Ethicon Endo—Srugery, Inc. | Thermodynamically driven reversible infuser pump for use as a remotely controlled gastric band |
US20050148956A1 (en) | 2004-06-01 | 2005-07-07 | Conlon Sean P. | Surgically implantable injection port having an improved fastener |
US20050283172A1 (en) | 2004-06-16 | 2005-12-22 | Conlon Sean P | Method of assembling an adjustable band |
US20060106288A1 (en) * | 2004-11-17 | 2006-05-18 | Roth Alex T | Remote tissue retraction device |
WO2006063593A2 (en) | 2004-12-14 | 2006-06-22 | Rune Wessel Weltlesen | A system and a method for treating of obesity by use of an intragastric balloon |
US7601162B2 (en) | 2005-01-14 | 2009-10-13 | Ethicon Endo-Surgery, Inc. | Actuator for an implantable band |
US8066629B2 (en) | 2005-02-24 | 2011-11-29 | Ethicon Endo-Surgery, Inc. | Apparatus for adjustment and sensing of gastric band pressure |
US20060253131A1 (en) | 2005-05-03 | 2006-11-09 | Endogastric Solutions, Inc. | Tissue fixation assemblies providing single stroke deployment |
CA2611963A1 (en) | 2005-05-10 | 2007-06-14 | Michael Gertner | Obesity treatment systems |
CA2618371A1 (en) | 2005-08-11 | 2007-02-15 | Adrian Paz | Implantable device for obesity prevention |
US20070073323A1 (en) * | 2005-09-26 | 2007-03-29 | Endogastric Solutions, Inc. | Apparatus for manipulating and fastening stomach tissue to treat gastroesophageal reflux disease |
US20070073318A1 (en) * | 2005-09-26 | 2007-03-29 | Endogastric Solutions, Inc. | Apparatus for manipulating and fastening stomach tissue to treat gastroesophageal reflux disease |
US20070255308A1 (en) | 2005-09-27 | 2007-11-01 | Williams Michael S | Procedural cannula for transgastric surgical procedures |
EP1937164A1 (en) | 2005-09-27 | 2008-07-02 | Synecor, LLC | Transgastric surgical devices and procedures |
US7509175B2 (en) * | 2006-08-03 | 2009-03-24 | Intrapace, Inc. | Method and devices for stimulation of an organ with the use of a transectionally placed guide wire |
US20070088373A1 (en) * | 2005-10-18 | 2007-04-19 | Endogastric Solutions, Inc. | Invaginator for gastroesophageal flap valve restoration device |
US20070112363A1 (en) * | 2005-11-15 | 2007-05-17 | Endogastric Solutions, Inc. | Apparatus including multiple invaginators for restoring a gastroesophageal flap valve and method |
US20070129738A1 (en) | 2005-12-01 | 2007-06-07 | Endogastric Solutions, Inc. | Apparatus and method for concurrently forming a gastroesophageal valve and tightening the lower esophageal sphincter |
ATE524145T1 (en) | 2005-12-22 | 2011-09-15 | Wilson Cook Medical Inc | ROLLED INTRAGASTIC ELEMENT FOR THE TREATMENT OF OBESITY |
US8398668B2 (en) | 2006-04-19 | 2013-03-19 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8342183B2 (en) | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8187297B2 (en) * | 2006-04-19 | 2012-05-29 | Vibsynt, Inc. | Devices and methods for treatment of obesity |
US20080109027A1 (en) * | 2006-08-01 | 2008-05-08 | Fulfillium, Inc. | Method and system for gastric volume control |
US20080058710A1 (en) * | 2006-08-15 | 2008-03-06 | Wilk Peter J | Surgical kit, closure device, and associated method |
US9326877B2 (en) | 2006-09-29 | 2016-05-03 | Apollo Endosurgery, Inc. | Apparatus and method for intragastric balloon with in situ adjustment means |
US20080086082A1 (en) * | 2006-10-06 | 2008-04-10 | Brooks Jeffrey S | Radiopaque marking to detect balloon deflation |
FR2907665B1 (en) | 2006-10-31 | 2009-04-17 | Cie Euro Etude Rech Paroscopie | IMPLANTABLE MEDICAL DEVICE WITH PRESSURE LIMITER |
US20080167519A1 (en) | 2007-01-10 | 2008-07-10 | Pascal St-Germain | Prosthetic repair patch with integrated sutures |
US20080172074A1 (en) | 2007-01-16 | 2008-07-17 | Endogastric Solutions, Inc. | Transesophageal gastric reduction method and device for practicing same |
-
2004
- 2004-07-30 CA CA2540653A patent/CA2540653C/en not_active Expired - Fee Related
- 2004-07-30 US US10/567,199 patent/US8192455B2/en not_active Expired - Fee Related
- 2004-07-30 AU AU2004266574A patent/AU2004266574B2/en not_active Ceased
- 2004-07-30 WO PCT/US2004/024612 patent/WO2005018417A2/en active Application Filing
- 2004-07-30 EP EP04779616A patent/EP1670525A4/en not_active Withdrawn
-
2011
- 2011-02-03 AU AU2011200448A patent/AU2011200448B2/en not_active Ceased
-
2012
- 2012-04-27 US US13/458,759 patent/US20120215249A1/en not_active Abandoned
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110106129A1 (en) * | 2004-10-27 | 2011-05-05 | Michael Gertner | Methods and devices to treat obesity |
US10137023B2 (en) | 2012-09-14 | 2018-11-27 | Medibotics Llc | Colonnade (TM) expandable intragastric food flow lumen device |
US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
Also Published As
Publication number | Publication date |
---|---|
US20070060940A1 (en) | 2007-03-15 |
EP1670525A4 (en) | 2008-06-11 |
AU2011200448A1 (en) | 2011-02-24 |
CA2540653C (en) | 2012-09-18 |
AU2004266574A1 (en) | 2005-03-03 |
WO2005018417A2 (en) | 2005-03-03 |
WO2005018417A3 (en) | 2005-05-06 |
AU2004266574B2 (en) | 2010-11-04 |
US8192455B2 (en) | 2012-06-05 |
AU2011200448B2 (en) | 2012-04-12 |
EP1670525A2 (en) | 2006-06-21 |
CA2540653A1 (en) | 2005-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8192455B2 (en) | Compressive device for percutaneous treatment of obesity | |
US7220284B2 (en) | Gastrointestinal sleeve device and methods for treatment of morbid obesity | |
US8083756B2 (en) | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach | |
US8911346B2 (en) | Gastric restriction devices with fillable chambers and ablation means for treating obesity | |
US8911393B2 (en) | Obesity treatment and device | |
EP1890658B1 (en) | Percutaneous intragastric balloon device | |
US20040044353A1 (en) | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach | |
US20210298935A1 (en) | Gastric restriction devices for treating obesity | |
CA2763674A1 (en) | Compressive device for percutaneous treatment of obesity | |
AU2012202674A1 (en) | Compressive device for percutaneous treatment of obesity | |
AU2014201234B2 (en) | Gastric restriction devices with fillable chambers and ablation means for treating obesity | |
BRPI0922794A2 (en) | gastric restriction devices with fillable chambers and ablation mechanisms for treating obesity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRAZZINI, AUGUSTO;KIRSCH, DAVID S.;CASTANEDA-ZUNIGA, WILFRIDO R.;AND OTHERS;SIGNING DATES FROM 20041006 TO 20041012;REEL/FRAME:028213/0278 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |